Practitioner Consultation – Dr. Khan

Practitioner / research consultation with our Medical Director Akbar Khan, MD, IMD, DHS, FAAO.

Medicor Cancer Centress / Sano Via Wellness Co-Founder and Medical Director
WONM (World Organization of Natural Medicine) Integrative Medical Doctor
WONM Doctor of Humanitarian Service
2023 WONM Humanitarian Health Icon Award Recipient
Fellow of the American Academy of Ozone Therapy

Your practitioner can gain valuable knowledge to enhance your care from Dr. Khan who is a recognized expert in the field of integrative medicine and one of the world leaders in the growing field of metabolic cancer therapy.

Dr. Khan has authored several leading publications about the clinical use of dichloroacetate (DCA) as a metabolic cancer therapy in humans. Dr. Khan was the first in the world to publish in peer-reviewed journals:

• the quality of life benefits of DCA (elimination of severe pain with cancer of unknown primary)
• synergism of DCA with radiation leading to cure (stage 4 kidney cancer)
• effectiveness of intravenous DCA in advanced cancers (case series examining sarcoma, pancreatic neuroendorcine carcinoma and colon carcinoma)
• long-term disease stabilization potential of DCA (case reports of stage 4 melanoma and colon carcinoma)
• clinical success of simultaneous glucose and glutamine blocking (as proposed by Prof. Thomas Seyfried).

Dr. Khan also published the first case report in the world of long-term complete remission of adenoid cystic carcinoma using only low dose naltrexone (LDN) and high dose vitamin D.